Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad377 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Jennifer L Ng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Keogh Institute for Medical Research, Sir Charles Gairdner Hospital, Nedlands, Western Australia 6009, Australia. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Cortodoxone. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Government Research Training Program Fees Offset.
Abstract (Originalsprache)
Context
Nonclassic congenital adrenal hyperplasia (NCCAH) requires exclusion before diagnosing polycystic ovary syndrome (PCOS). Increasing use of liquid chromatography and tandem mass spectrometry (LC-MS/MS) necessitates revision of immunoassay-based criteria for NCCAH. Measurement of 21-deoxycortisol (21DF) may simplify the diagnosis of heterozygosity (HTZ), the presence of 1 affected CYP21A2 allele, which currently relies on complex molecular studies.
Objective
We aimed to determine LC-MS/MS-specific criteria for NCCAH and HTZ and compare the diagnostic accuracy of 21DF and 17-hydroxyprogesterone (17OHP).
Methods
A cross-sectional study involving 99 hyperandrogenic females was performed. We identified females who had undergone both a synacthen stimulation test (SST) and CYP21A2 genotyping from 2010 to 2017, and prospectively recruited females referred for an SST to investigate hyperandrogenic symptoms from 2017 to 2021. Steroids were compared between genetically confirmed NCCAH, HTZ, and PCOS. Optimal 17OHP and 21DF thresholds for HTZ and NCCAH were determined by receiver operating characteristic analysis.
Results
Basal 17OHP, stimulated 17OHP, and 21DF were measured in 99, 85, and 42 participants, respectively. Optimal thresholds for NCCAH were 3.0 nmol/L and 20.7 nmol/L for basal and stimulated 17OHP, respectively. Basal and stimulated 21DF thresholds of 0.31 nmol/L and 13.3 nmol/L provided 100% sensitivity with specificities of 96.8% and 100% for NCCAH, respectively. Diagnostic thresholds for HTZ of 8.0 nmol/L, 1.0 nmol/L, and 13.6 for stimulated 17OHP, 21DF, and the ratio (21DF + 17OHP)/cortisol each provided 100% sensitivity with specificities of 80.4%, 90.5%, and 85.0%, respectively.
Conclusion
LC-MS/MS-specific 17OHP thresholds for NCCAH are lower than those based on immunoassay. LC-MS/MS-quantified 17OHP and 21DF accurately discriminate HTZ and NCCAH from PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Keogh Institute for Medical Research, Sir Charles Gairdner Hospital, Nedlands, Western Australia 6009, Australia.
- PathWest Laboratory Medicine, Department of Chemical Pathology, QEII Medical Centre, Nedlands, Western Australia 6009, Australia.
- Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, , Nedlands, Western Australia 6009, Australia.
- School of Biomedical Sciences, The University of Western Australia, Crawley, Western Australia 6009, Australia.
- Cardiometabolic Service, Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia 6000, Australia.
- Medical School, University of Western Australia, Crawley, Western Australia 6009, Australia.
ORCID-Profile: Jennifer L Ng
Förderung
- Australian Government Research Training Program Fees Offset
Zitieren
APA
Ng, J. L., Lim, E. M., Zhang, R., Beilby, J. P., Watts, G. F., Brown, S. J., & Stuckey, B. G. A. (2023). Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad377
Vancouver
Ng JL, Lim EM, Zhang R, Beilby JP, Watts GF, Brown SJ, et al. Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad377
BibTeX
@article{Ng2023,
author = {Ng, Jennifer L and Lim, Ee Mun and Zhang, Rui and Beilby, John P and Watts, Gerald F and Brown, Suzanne J and Stuckey, Bronwyn G A},
title = {Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad377}
}
EUVIMED